National survey of neonatal transfusion practices

I. Red blood cell therapy

G. J. Levy, R. G. Strauss, H. Hume, L. Schloz, M. A. Albanese, J. Blazina, A. Werner, C. Sotelo-Avila, C. Barrasso, V. Blanchette, Phyllis Irene Warkentin, S. Pepkowitz, A. M. Mauer, D. Hines

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Neonatal blood component transfusion practices during 1989 were surveyed via a questionnaire developed by the Pediatric Hemotherapy Committee of the American Association of Blood Banks. Of 1790 questionnaires mailed, 452 were selected to form the database for this analysis because they were from institutions in which neonates were transfused. Nearly all institutions contained intensive care units directed by neonatologists and were involved in the management of high-risk infants. Results from institutions serving as the primary pediatric teaching hospital of a medical school were compared with those with no medical school affiliation. Thirty-six percent of primary pediatric teaching hospitals and 52% of hospitals with no medical school affiliation performed pretransfusion testing in excess of that required, resulting in additional blood loss in neonates. Sixty-six percent of primary pediatric teaching hospitals used fresh frozen plasma to adjust the hematocrit of red blood cell concentrates prior to transfusion (a practice increasing donor exposure), compared with only 29% of hospitals with no medical school affiliation. The usual indication for small-volume red blood cell transfusions in severely ill neonates was to maintain a desired hematocrit level, whereas for stable infants, red blood cell transfusions were given to treat symptomatic anemia, rather than to maintain a predetermined hematocrit. As found in 1985, neonatal transfusion practices in 1989 were variable. However, improvements have occurred since 1985 to suggest that further research and educational efforts may serve to promote even better neonatal transfusion therapy.

Original languageEnglish (US)
Pages (from-to)523-529
Number of pages7
JournalPediatrics
Volume91
Issue number3
StatePublished - Jan 1 1993

Fingerprint

Cell- and Tissue-Based Therapy
Medical Schools
Pediatric Hospitals
Erythrocytes
Hematocrit
Teaching Hospitals
Erythrocyte Transfusion
Newborn Infant
Blood Component Transfusion
Risk Management
Intensive Care Units
Anemia
Tissue Donors
Databases
Pediatrics
Surveys and Questionnaires
Research
Therapeutics

Keywords

  • additive solutions
  • compatibility testing
  • directed donors
  • neonatal transfusions
  • red blood cells

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Levy, G. J., Strauss, R. G., Hume, H., Schloz, L., Albanese, M. A., Blazina, J., ... Hines, D. (1993). National survey of neonatal transfusion practices: I. Red blood cell therapy. Pediatrics, 91(3), 523-529.

National survey of neonatal transfusion practices : I. Red blood cell therapy. / Levy, G. J.; Strauss, R. G.; Hume, H.; Schloz, L.; Albanese, M. A.; Blazina, J.; Werner, A.; Sotelo-Avila, C.; Barrasso, C.; Blanchette, V.; Warkentin, Phyllis Irene; Pepkowitz, S.; Mauer, A. M.; Hines, D.

In: Pediatrics, Vol. 91, No. 3, 01.01.1993, p. 523-529.

Research output: Contribution to journalArticle

Levy, GJ, Strauss, RG, Hume, H, Schloz, L, Albanese, MA, Blazina, J, Werner, A, Sotelo-Avila, C, Barrasso, C, Blanchette, V, Warkentin, PI, Pepkowitz, S, Mauer, AM & Hines, D 1993, 'National survey of neonatal transfusion practices: I. Red blood cell therapy', Pediatrics, vol. 91, no. 3, pp. 523-529.
Levy GJ, Strauss RG, Hume H, Schloz L, Albanese MA, Blazina J et al. National survey of neonatal transfusion practices: I. Red blood cell therapy. Pediatrics. 1993 Jan 1;91(3):523-529.
Levy, G. J. ; Strauss, R. G. ; Hume, H. ; Schloz, L. ; Albanese, M. A. ; Blazina, J. ; Werner, A. ; Sotelo-Avila, C. ; Barrasso, C. ; Blanchette, V. ; Warkentin, Phyllis Irene ; Pepkowitz, S. ; Mauer, A. M. ; Hines, D. / National survey of neonatal transfusion practices : I. Red blood cell therapy. In: Pediatrics. 1993 ; Vol. 91, No. 3. pp. 523-529.
@article{958902abeff546cd911800809ff7e594,
title = "National survey of neonatal transfusion practices: I. Red blood cell therapy",
abstract = "Neonatal blood component transfusion practices during 1989 were surveyed via a questionnaire developed by the Pediatric Hemotherapy Committee of the American Association of Blood Banks. Of 1790 questionnaires mailed, 452 were selected to form the database for this analysis because they were from institutions in which neonates were transfused. Nearly all institutions contained intensive care units directed by neonatologists and were involved in the management of high-risk infants. Results from institutions serving as the primary pediatric teaching hospital of a medical school were compared with those with no medical school affiliation. Thirty-six percent of primary pediatric teaching hospitals and 52{\%} of hospitals with no medical school affiliation performed pretransfusion testing in excess of that required, resulting in additional blood loss in neonates. Sixty-six percent of primary pediatric teaching hospitals used fresh frozen plasma to adjust the hematocrit of red blood cell concentrates prior to transfusion (a practice increasing donor exposure), compared with only 29{\%} of hospitals with no medical school affiliation. The usual indication for small-volume red blood cell transfusions in severely ill neonates was to maintain a desired hematocrit level, whereas for stable infants, red blood cell transfusions were given to treat symptomatic anemia, rather than to maintain a predetermined hematocrit. As found in 1985, neonatal transfusion practices in 1989 were variable. However, improvements have occurred since 1985 to suggest that further research and educational efforts may serve to promote even better neonatal transfusion therapy.",
keywords = "additive solutions, compatibility testing, directed donors, neonatal transfusions, red blood cells",
author = "Levy, {G. J.} and Strauss, {R. G.} and H. Hume and L. Schloz and Albanese, {M. A.} and J. Blazina and A. Werner and C. Sotelo-Avila and C. Barrasso and V. Blanchette and Warkentin, {Phyllis Irene} and S. Pepkowitz and Mauer, {A. M.} and D. Hines",
year = "1993",
month = "1",
day = "1",
language = "English (US)",
volume = "91",
pages = "523--529",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "3",

}

TY - JOUR

T1 - National survey of neonatal transfusion practices

T2 - I. Red blood cell therapy

AU - Levy, G. J.

AU - Strauss, R. G.

AU - Hume, H.

AU - Schloz, L.

AU - Albanese, M. A.

AU - Blazina, J.

AU - Werner, A.

AU - Sotelo-Avila, C.

AU - Barrasso, C.

AU - Blanchette, V.

AU - Warkentin, Phyllis Irene

AU - Pepkowitz, S.

AU - Mauer, A. M.

AU - Hines, D.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Neonatal blood component transfusion practices during 1989 were surveyed via a questionnaire developed by the Pediatric Hemotherapy Committee of the American Association of Blood Banks. Of 1790 questionnaires mailed, 452 were selected to form the database for this analysis because they were from institutions in which neonates were transfused. Nearly all institutions contained intensive care units directed by neonatologists and were involved in the management of high-risk infants. Results from institutions serving as the primary pediatric teaching hospital of a medical school were compared with those with no medical school affiliation. Thirty-six percent of primary pediatric teaching hospitals and 52% of hospitals with no medical school affiliation performed pretransfusion testing in excess of that required, resulting in additional blood loss in neonates. Sixty-six percent of primary pediatric teaching hospitals used fresh frozen plasma to adjust the hematocrit of red blood cell concentrates prior to transfusion (a practice increasing donor exposure), compared with only 29% of hospitals with no medical school affiliation. The usual indication for small-volume red blood cell transfusions in severely ill neonates was to maintain a desired hematocrit level, whereas for stable infants, red blood cell transfusions were given to treat symptomatic anemia, rather than to maintain a predetermined hematocrit. As found in 1985, neonatal transfusion practices in 1989 were variable. However, improvements have occurred since 1985 to suggest that further research and educational efforts may serve to promote even better neonatal transfusion therapy.

AB - Neonatal blood component transfusion practices during 1989 were surveyed via a questionnaire developed by the Pediatric Hemotherapy Committee of the American Association of Blood Banks. Of 1790 questionnaires mailed, 452 were selected to form the database for this analysis because they were from institutions in which neonates were transfused. Nearly all institutions contained intensive care units directed by neonatologists and were involved in the management of high-risk infants. Results from institutions serving as the primary pediatric teaching hospital of a medical school were compared with those with no medical school affiliation. Thirty-six percent of primary pediatric teaching hospitals and 52% of hospitals with no medical school affiliation performed pretransfusion testing in excess of that required, resulting in additional blood loss in neonates. Sixty-six percent of primary pediatric teaching hospitals used fresh frozen plasma to adjust the hematocrit of red blood cell concentrates prior to transfusion (a practice increasing donor exposure), compared with only 29% of hospitals with no medical school affiliation. The usual indication for small-volume red blood cell transfusions in severely ill neonates was to maintain a desired hematocrit level, whereas for stable infants, red blood cell transfusions were given to treat symptomatic anemia, rather than to maintain a predetermined hematocrit. As found in 1985, neonatal transfusion practices in 1989 were variable. However, improvements have occurred since 1985 to suggest that further research and educational efforts may serve to promote even better neonatal transfusion therapy.

KW - additive solutions

KW - compatibility testing

KW - directed donors

KW - neonatal transfusions

KW - red blood cells

UR - http://www.scopus.com/inward/record.url?scp=0027497774&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027497774&partnerID=8YFLogxK

M3 - Article

VL - 91

SP - 523

EP - 529

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 3

ER -